We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




CT Contrast Media Does Not Increase Kidney Injury Risk

By HospiMedica International staff writers
Posted on 09 Feb 2017
Intravenous (IV) contrast media administration for computerized tomography (CT) is not associated with an increased frequency of acute kidney injury (AKI), according to a new study.

Researchers at Johns Hopkins University School of Medicine conducted a retrospective cohort analysis involving 17,934 emergency department (ED) visits for patients who underwent contrast-enhanced, unenhanced, or no CT between 2009 and 2014. More...
The primary outcome was incidence of AKI, with secondary outcomes including new chronic kidney disease (CKD), dialysis, and renal transplantation at six months.

In addition, treatment decisions, including administration of contrast media--typically iohexol or iodixanol--and IV fluids were examined. The results showed that 57.2% of all CT scans were contrast-enhanced. Contrast administration was not associated with increased incidence of AKI, in all subgroup analyses, regardless of baseline renal function. The probability of developing acute kidney injury was 6.8% for patients undergoing contrast-enhanced CT, 8.9% for patients receiving unenhanced CT, and 8.1% for patients not receiving CT at all.

In addition, IV contrast administration was not associated with increased incidence of any of the secondary outcomes. Clinicians were less likely to prescribe contrast to patients with decreased renal function and more likely to prescribe IV fluids if contrast was administered. The study was published on January 27, 2017, in Annals of Emergency Medicine.

“Our results clearly demonstrate that in emergency departments such as ours where practice patterns have evolved to protect patients' kidneys, contrast media is not associated with increased risk of kidney injury,” said lead author Jeremiah Hinson, MD. “Our data also suggest that in cases where contrast-enhanced CT is indicated to avoid delayed or missed diagnosis of critical disease, the potential morbidity and mortality resulting from a failure to diagnose potentially life-threatening conditions likely outweigh any potential risk of kidney injury.”

AKI is an abrupt loss of kidney function that develops within seven days, generally caused by decreased renal ischemia, exposure to substances harmful to the kidney, an inflammatory process in the kidney, or an obstruction of the urinary tract. AKI can lead to several complications, including metabolic acidosis, high potassium levels, uremia, changes in body fluid balance, and effects on other organ systems. Those who have experienced AKI may have an increased risk of CKD in the future.


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.